✦ LIBER ✦

W1119 Rikkunshito Improves PPI-Refractory NERD: A Prospective Randomized MultiCenter Trial in Japan

✍ Scribed by Tominaga, Kazunari; Fujiwara, Yasuhiro; Shimoyama, Yasuyuki; Umegaki, Eiji; Iwakiri, Ryuichi; Higuchi, Kazuhide; Kusano, Motoyasu; Fujimoto, Kazuma; Arakawa, Tetsuo

Book ID: 123022944
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 215 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63015-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rikkunshito improves symptoms in PPI-ref

Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan

✍ Kazunari Tominaga; Ryuichi Iwakiri; Kazuma Fujimoto; Yasuhiro Fujiwara; Mio Tana 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 436 KB

Mo1075 Clinical Characteristics of Respo

Mo1075 Clinical Characteristics of Responders for Rikkunshito and Rabeprazole in Patients With PPI-Refractory NERD From the GERD 4 Study (a Prospective Randomized Multicenter Trial in Japan)

✍ Tominaga, Kazunari; Iwakiri, Ryuichi; Fujimoto, Kazuma; Fujiwara, Yasuhiro; Shim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Prospective randomized open-label multic

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis

✍ Daniel C. Baumgart; Stephan R. Targan; Axel U. Dignass; Lloyd Mayer; Gert van As 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

## Background: Visilizumab is a humanized igg(2) monoclonal anti-cd3 antibody. we evaluated its safety and dose response in severe intravenous steroid-refractory ulcerative colitis (uc). ## Methods: In all, 104 patients were treated. in stage i, 73 patients were randomly assigned to receive intra

A significant reduction in serum alanine

A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan

✍ Motoyoshi Yano; Hisao Hayashi; Kentaro Yoshioka; Yutaka Kohgo; Hiroyuki Saito; Y 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 252 KB

Transjugular intrahepatic portosystemic

Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial

✍ Yoshiyuki Narahara; Hidenori Kanazawa; Takeshi Fukuda; Yoko Matsushita; Hirotomo 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 217 KB

Prochymal Improves Response Rates In Pat

Prochymal Improves Response Rates In Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-GVHD) Involving The Liver And Gut: Results Of A Randomized, Placebo-Controlled, Multicenter Phase III Trial In GVHD

✍ P.J. Martin; J.P. Uberti; R.J. Soiffer; H. Klingemann; E.K. Waller; A.S. Daly; R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 93 KB